resveratrol microdose
Longevity Science Why Resveratrol Microdose Fails You
A 2022 meta-analysis of six placebo-controlled trials showed a 3.2% slowing of epigenetic aging in resveratrol users, proving that microdosing can modestly extend healthspan - but only when the dose, timing, and individual genetics align, otherwise the regimen falls short. Medical Disclaimer: This article is for informational purposes only